Nov 15, 2021 / 07:15PM GMT
Yaron Benjamin Werber - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
All right. Well, good afternoon, everybody, and thank you for joining us again at this year's IO Summit. I'm Yaron Werber from the biotech team at Cowen. With me here today is my colleague, Gabe Schneider, and it's a great pleasure for both of us to co-moderate this session with Amgen.
Today, we have David Reese, who's EVP of R&D; and also Jean-Charles Soria, who's SVP, Global Development Oncology. So gentlemen, thank you so much for joining us. Really appreciate it.
David M. Reese - Amgen Inc. - EVP of Research & Development
Great to see you, Yaron.
Jean-Charles Soria - Amgen Inc. - SVP of Research & Development
Our pleasure.
Questions and Answers:
Yaron Benjamin Werber - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology AnalystThere's a lot to talk about. So we are focusing more on the IO pipeline,